BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36588856)

  • 21. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Could Serve as a Potential Serological Biomarker for the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
    Xie J; Li Y; Kong J; Li C
    J Oral Maxillofac Surg; 2019 Apr; 77(4):859-866. PubMed ID: 30611690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA SAMMSON as a novel potential diagnostic and prognostic biomarker for oral squamous cell carcinoma.
    Zheng X; Tian X; Zhang Q; Shi P; Li S
    J Dent Sci; 2020 Sep; 15(3):329-335. PubMed ID: 32952891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of Serum Butyryl Cholinesterase in Patients with Oral Squamous Cell Carcinoma: A Cross-Sectional Study.
    Nair KK; Pramod GV; Chaudhuri K; Ashok L
    J Clin Diagn Res; 2017 Jul; 11(7):ZC59-ZC62. PubMed ID: 28893045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma.
    Schiegnitz E; Kämmerer PW; Koch FP; Krüger M; Berres M; Al-Nawas B
    Oral Oncol; 2012 Jul; 48(7):608-14. PubMed ID: 22341306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The balance of serum IL-18/IL-37 levels is disrupted during the development of oral squamous cell carcinoma.
    Ding L; Zhao X; Zhu N; Zhao M; Hu Q; Ni Y
    Surg Oncol; 2020 Mar; 32():99-107. PubMed ID: 31983439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma.
    Shao T; Huang J; Zheng Z; Wu Q; Liu T; Lv X
    Cell Physiol Biochem; 2018; 47(1):26-38. PubMed ID: 29763905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
    Tang Y; Xiao Y; Liao R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Decreased Expression of Serum miR-9 with Poor Prognosis of Oral Squamous Cell Carcinoma Patients.
    Sun L; Liu L; Fu H; Wang Q; Shi Y
    Med Sci Monit; 2016 Jan; 22():289-94. PubMed ID: 26813876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenosine Deaminase - a Novel Diagnostic and Prognostic Biomarker for Oral Squamous Cell Carcinoma.
    Kelgandre DC; Pathak J; Patel S; Ingale P; Swain N
    Asian Pac J Cancer Prev; 2016; 17(4):1865-8. PubMed ID: 27221867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum C-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: A cross-sectional study.
    Gosavi SR; Torkadi AA
    J Oral Maxillofac Pathol; 2020; 24(1):46-51. PubMed ID: 32508447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Family with Sequence Similarity 72 (FAM72) - A prospective biomarker for poor prognosis in patients with oral squamous cell carcinoma.
    Liu H; Huang Y; Chen Y; Tang Z; Huang M; Ming Y; Wang M; Chen W; Huang Z; Qing L; Wang Q; Jia B
    Arch Oral Biol; 2023 Jul; 151():105695. PubMed ID: 37086493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma.
    Malhotra R; Urs AB; Chakravarti A; Kumar S; Gupta VK; Mahajan B
    Tumour Biol; 2016 Jul; 37(7):9263-71. PubMed ID: 26779624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of serum lipids and lipoproteins as prognosticators in leukoplakia.
    Ganavi BS; Patil S; Rao RS
    J Contemp Dent Pract; 2014 May; 15(3):294-9. PubMed ID: 25307809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-105 Promotes the Progression and Predicts the Prognosis for Oral Squamous Cell Carcinoma (OSCC).
    Zhang HY; Ma JH
    Cancer Manag Res; 2020; 12():11491-11499. PubMed ID: 33204160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.
    Bose P; Klimowicz AC; Kornaga E; Petrillo SK; Matthews TW; Chandarana S; Magliocco AM; Brockton NT; Dort JC
    BMC Cancer; 2012 Aug; 12():332. PubMed ID: 22852863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
    Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
    J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
    Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
    J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.